As big pharmaceutical companies are set to finalize a deal with the U.S. government to bring down prices for some prescription drugs, another old question is coming into focus for investors: how much damage can Washington really do to Big Pharma’s bottom line?The answer for ETF investors may be f... Read more
Benzinga - Dec 19
Big Pharma has told its version of the story long enough. It is time for honesty to make a comeback. Read more
The Hill - Nov 02
do the right thing Read more
Dailycaller - Oct 20
Americans pay four times as much for medicines than Brits as campaigners demand the UK government resists Trump's threats - amid fears the NHS could ‘go broke’ Read more
Mirror - Oct 10
Several pharmaceutical companies have said they will sell drugs direct to patients in the U.S. and offered discounts following President Donald Trump’s calls to bring down drug prices and cut out “middlemen” like pharmacies, insurers and pharmacy benefit managers.The Trump administration announce... Read more
Fast Company - Oct 01
The pharma giants' multibillion spending promises come as drugmakers look to mitigate the threat of levies on imported medicines Read more
Quartz - Sep 17
Unable to find treatment, parents of children with Infantile Neuroaxonal Dystrophy are taking it upon themselves to fund scientific progress. Read more
Nj - Aug 24
Ads don’t encourage thoughtful conversations with primary care physicians — they push viewers toward medication-only solutions, skewing conversations away from lifestyle choices. Read more
Boston Herald - Aug 15
GSK is expected to report profit of £4.4 billion for the first half of this year. AstraZeneca is forecast to report a half-year profit of £5 billion. Read more
Mail Online - Jul 26
